DOCSLIB.ORG

International 2017 2 Table of Contents

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
International 2017 2 Table of Contents Deuterium Labelled Compounds International 2017 2 Table of Contents International Distributors 3 Corporate Overview 4 General Information 5 Quality Control 5 Custom Synthesis 5 Chemical Abstract Service Numbers 5 Handling Hazardous Compounds 5 Our Products are Not Intended for Use in Humans 6 Limited Warranty 6 Packaging Information 6 Alphabetical Listings 7 Stock Clearance 235 Products by Category 241 n-Alkanes 242 α-Amino Acids, N-Acyl α-Amino Acids, N-t-BOC Protected α-Amino Acids 242 and N-FMOC Protected α-Amino Acids Buffers and Reagents for NMR Studies 244 Detergents 244 Environmental Standards 245 Fatty Acids and Fatty Acid Esters 248 Flavours and Fragrances 249 Gases 252 Medical Research Products 253 Nucleic Acid Bases and Nucleosides 254 Pesticides and Pesticide Metabolites 255 Pharmaceutical Standards 256 Polyaromatic Hydrocarbons (PAHs), Alkyl-PAHs, Amino-PAHs, 259 Hydroxy-PAHs and Nitro-PAHs Polychlorinated Biphenyls (PCBs) 259 Spin Labels 260 Steroids 260 3 International Distributors C Beijng Zhenxiang H EQ Laboratories GmbH Australia K Technology Company Graf-von-Seyssel-Str. 10 Rm. 15A01, Changyin Bld. 86199 Augsburg Austria H No. 88, YongDingLu Rd. Germany Beijing 100039 Tel.: (49) 821 71058246 Belgium J China Fax: (49) 821 71058247 Tel.: (86) 10-58896805 [email protected] China C Fax: (86) 10-58896158 www.eqlabs.de Czech Republic H [email protected] Germany, Austria, China Czech Republic, Greece, Denmark I Hungary, Poland, Switzerland D Central Chemicals Co., Inc. Estonia I Ishida Bldg., 4-chome 2-17 I QMX Laboratories Limited Nihonbashi-hongokucho Bolford Street Finland I Chuo-ku, Tokyo 103-0021 Thaxted, Essex CM6 2PY Japan United Kingdom France G Tel.: (81) 03 3242 1541 Tel.: (44) 1371 831611 Fax: (81) 03 3246 2566 Fax: (44) 1371 831622 Germany H [email protected] [email protected] www.qmx.com Greece H www.centralchem.co.jp United Kingdom, Ireland, Japan Denmark, Estonia, Finland, Hungary H Latvia, Lithuania, Sweden E Chemical Research 2000 S.r.l. Ireland I Via Santa Margherita di Belice, 16-18 J J.H. Ritmeester B.V. 00133 Roma Ravenswade 66 Italy E Italy 3439 LD Nieuwegein Tel.: (39) 06 20630997 Netherlands Japan D Fax: (39) 06 20685490 Tel.: (31) 30 231 6422 Latvia I [email protected] www.cr2000.it Fax: (31) 30 233 1179 Italy, Croatia, Slovenia, Turkey [email protected] Lithuania I www.ritmeesterbv.nl F Chiron AS Netherlands, Belgium, Luxembourg J Stiklestadveien 1 Luxembourg N-7041 Trondheim Netherlands J Norway K SciVac PTY. Ltd. Tel.: (47) 73 87 44 90 231 Pacific Highway New Zealand K Fax: (47) 73 87 44 99 Hornsby, NSW 2077 [email protected] Australia Norway F www.chiron.no Tel.: (61) 2 9940 4077 Poland H Norway Fax: (61) 2 9940 4076 [email protected] Portugal G G Cluzeau Info Labo www.scivac.com.au 33-35 rue Jean-Louis Faure Australia, New Zealand Republic of Korea L 33220 Sainte Foy La Grande France L Seojin International Co. Slovenia E Tel.: (33) 05 57 46 00 44 #88-31, Singil 1-Dong Fax: (33) 05 57 46 53 96 Youngdeugpo-Gu Spain G [email protected] Seoul Sweden I www.cluzeau.com Republic of Korea France, Portugal, Spain Tel.: (82) 2-846-1211 Switzerland H Fax: (82) 2-846-9211 [email protected] Turkey E www.sjintnl.co.kr Republic of Korea United Kingdom I 4 Corporate Overview Leaders in the development of deuterated compounds Fast and courteous service A reputation for high quality products Competitive Prices An extensive inventory Since 1993, C/D/N Isotopes Inc. has provided its customers with superior quality and exceptional service. Researchers in all branches of science and medicine, from around the world, depend on C/D/N Isotopes as the company for deuterium labelled compounds. We currently have more than 3300 products in stock. As a result, we are able to ship most products within 24 to 48 hours after receipt of order. In fact, 98% of our orders are filled from stock. The majority of the products listed in this catalog are manufactured exclusively by C/D/N Isotopes. Over the years, we have developed and expanded our expertise in the preparation of deuterated compounds. As a result, we are continuously adding new products. Most new products are the direct result of inquiries from our customers. Our extensive Custom Synthesis capabilities allow us to develop the products that our customers need, in a timely manner and at a reasonable price. Our Quality Control ensures that the isotopic enrichment and chemical purity of our products meet the highest standards. Add to this our fast, courteous and helpful Customer Service staff, and there is no better company to meet your needs for deuterated compounds. 5 General Information Quality Control The listed Isotopic Enrichments are our minimum specifications for Quality Control release. The minimum standard for Chemical Purity is 98%, unless noted otherwise. A Certificate of Analysis is provided with each product shipped, with the exception of NMR Solvents. All of our products are non-radioactive and have a shelf life comparable to that of the corresponding unlabelled compounds. Custom Synthesis Please ask us about labelled compounds you do not find listed. The product that you need may have been prepared already, but is not included in this catalog. We would be pleased to provide you with a quote for custom synthesis. Our extensive expertise in the preparation of stable isotope labelled compounds allows us to offer custom synthesis of products to meet your specific requirements. Contact our Technical Support staff to ask how we can meet your research requirements. Chemical Abstract Service Numbers CAS Numbers, when they have been assigned to the labelled compound, are provided in brackets under the compound name. You will also find the Unlabelled CAS Numbers, which correspond to the unlabelled version of the compound, on our website. Handling Hazardous Compounds The listed products have properties and potential hazards similar to the corresponding unlabelled chemicals. Appropriate precautions should be taken at all times during their use and disposal. A Material Safety Data Sheet (MSDS) is provided with each product shipped. MSDSs for our products are also available on our website at: www.cdnisotopes.com 6 General Information Our products are not intended for use in humans They are offered for use as analytical standards and laboratory chemicals only. Approval from the appropriate government regulatory agency should be obtained prior to studies in which any labelled compounds are to be administered to humans. Limited warranty C/D/N Isotopes Inc. warrants that the products are as described when shipped. There is no warranty, expressed or implied, as to the fitness of the compounds for any particular application. Quality claims should be made within 30 days of receipt of product. The maximum liability for C/D/N Isotopes Inc. shall be the replacement of the product or the refund of the purchase price. Packaging Information We use packaging components which permit easy and safe handling, while protecting the integrity of the products. Liquid products, including NMR Solvents, are sealed in ampoules or are packaged in screw-cap bottles, when appropriate. Multi-dose septum vials are used for selected products. Solids are generally packaged in screw-cap bottles. Gases are routinely packaged in carbon-steel lecture bottles. Non-Corrosive Gases: The cylinder is fitted with a CGA 170 brass valve. Corrosive Gases: The cylinder is fitted with a CGA 180 aluminum-silicon-bronze Certain other products are packaged in cylinders due to shipping regulations. Smaller quantities of gases, such as 0.05 L, 0.1 L, 0.25 L and 0.5 L, can be packaged in breakseal glass flasks, upon request. Lecture bottles are sold outright with the product and are non-refundable. 7 Deuterium Labelled Compounds Alphabetical Listings 8 Alphabetical Listings D-7500 Acamprosate-d6 Calcium (diacetyl-d6) D-0163 Acetaldehyde-d4 CAS [77337-73-6] MW 406.51 99 atom % D CAS [1632-89-9] MW 48.08 99 atom % D (CD3CONHCH2CH2CH2SO3)2Ca 0.005 g CD3CDO 1 g NON-HAZARDOUS FOR TRANSPORT 0.01 g FLAMMABLE LIQUID D-7381 Acamprosate-d12 Calcium (di-п-propyl-d12) D-5134 Acetaldehyde-d4 Diethyl Acetal MW 412.55 99 atom % D (Acetal; 1,1-Diethoxyethane) 98 atom % D (CH3CONHCD2CD2CD2SO3)2Ca 0.005 g CAS [352438-71-2] MW 122.20 0.5 g NON-HAZARDOUS FOR TRANSPORT 0.01 g CD3CD(OCH2CH3)2 1 g FLAMMABLE LIQUID D-7506 (±)-Acebutolol-d7 (iso-propyl-d7) MW 343.47 99 atom % D D-6026 Acetaldehyde Dimethyl Acetal-d10 NON-HAZARDOUS FOR TRANSPORT 0.005 g (1,1-Dimethoxyethane) 98 atom % D 0.01 g CAS [1219798-83-0] MW 100.18 0.5 g CD3CD(OCD3)2 1 g FLAMMABLE LIQUID D-7049 Acetaldehyde 2,4-Dinitrophenylhydrazone-3,5,6-d3 CAS [259824-51-6] MW 227.19 99 atom % D CH3CH=NNHC6D3(NO2)2 0.01 g D-7574 Aceclofenac-d4 (phenyl-d4-acetoxy) NON-HAZARDOUS FOR TRANSPORT 0.05 g MW 358.21 97 atom % D TOXIC 0.005 g D-0090 Acetamide-2,2,2-d3 0.01 g CAS [23724-60-9] MW 62.09 99 atom % D CD3CONH2 0.5 g NON-HAZARDOUS FOR TRANSPORT 1 g D-0228 Acetamide-d5 CAS [33675-83-1] MW 64.10 99 atom % D CD3COND2 0.5 g D-0042 Acenaphthene-d10 NON-HAZARDOUS FOR TRANSPORT 1 g CAS [15067-26-2] MW 164.27 99 atom % D NON-HAZARDOUS FOR TRANSPORT 1 g D-7394 4-Acetamidobenzene-d4-sulfonyl Chloride 5 g CAS [77435-44-0] MW 237.69 98 atom % D CH3CONHC6D4SO2Cl 0.5 g CORROSIVE 1 g Acetaminophen D-0128 Acenaphthylene-d8 SEE N-(4-Hydroxyphenyl)acetamide CAS [93951-97-4] MW 160.24 99 atom % D NON-HAZARDOUS FOR TRANSPORT 0.1 g Acetaminophen, Sodium Sulfate Salt 0.5 g SEE Sodium N-(4-Hydroxyphenyl)acetamide Sulfate D-7632 Acetamiprid-d3 (N-methyl-d3) (mixture of isomers) MW 225.70 99 atom % D TOXIC 0.01 g Acetal 0.05 g SEE Acetaldehyde Diethyl Acetal D-0682 Acetaldehyde-2,2,2-d3 CAS [19901-15-6] MW 47.07 98 atom % D CD3CHO 0.5 g D-0894 Acetanilide-2’,3’,4’,5’,6’-d5 FLAMMABLE LIQUID 1 g CAS [15826-91-2] MW 140.20 99 atom % D CH3CONHC6D5 0.5 g NON-HAZARDOUS FOR TRANSPORT 1 g 98% OF OUR ORDERS SHIP FROM STOCK.
Load more

Recommended publications
  • United States July 2016 2 Table of Contents
    Deuterium Labelled Compounds United States July 2016 2 Table of Contents International Distributors 3 Corporate Overview 4 General Information 5 Pricing and Payment 5 Quotations 5 Custom Synthesis 5 Shipping 5 Quality Control 6 Quotations 6 Custom Synthesis 6 Shipping 6 Quality Control 6 Chemical Abstract Service Numbers 6 Handling Hazardous Compounds 6 Our Products are Not Intended for Use in Humans 7 Limited Warranty 7 Packaging Information 7 Alphabetical Listings 8 Stock Clearance 236 Products by Category 242 n-Alkanes 243 α-Amino Acids, N-Acyl α-Amino Acids, N-t-BOC Protected α-Amino Acid 243 and N-FMOC Protected α-Amino Acids Buffers and Reagents for NMR Studies 245 Detergents 245 Environmental Standards 246 Fatty Acids and Fatty Acid Esters 249 Flavours and Fragrances 250 Gases 253 Medical Research Products 254 Nucleic Acid Bases and Nucleosides 255 Pesticides and Pesticide Metabolites 256 Pharmaceutical Standards 257 Polyaromatic Hydrocarbons (PAHs), Alkyl-PAHs, Amino-PAHs, 260 Hydroxy-PAHs and Nitro-PAHs Polychlorinated Biphenyls (PCBs) 260 Spin Labels 261 Steroids 261 3 International Distributors C Beijng Zhenxiang H EQ Laboratories GmbH Australia K Technology Company Graf-von-Seyssel-Str. 10 Rm. 15A01, Changyin Bld. 86199 Augsburg Austria H No. 88, YongDingLu Rd. Germany Beijing 100039 Tel.: (49) 821 71058246 Belgium J China Fax: (49) 821 71058247 Tel.: (86) 10-58896805 [email protected] China C Fax: (86) 10-58896158 www.eqlabs.de Czech Republic H [email protected] Germany, Austria, China Czech Republic, Greece, Denmark I Hungary,
    [Show full text]
  • C:\Data\Ndaenjuvia\AP LTR 05-07-04
    NDA 21-443 Package Insert ENJUVIA™ (synthetic conjugated estrogens, B) Tablets Rx only ESTROGENS INCREASE THE RISK OF ENDOMETRIAL CANCER Close clinical surveillance of all women taking estrogens is important. Adequate diagnostic measures, including endometrial sampling when indicated, should be undertaken to rule out malignancy in all cases of undiagnosed persistent or recurring abnormal vaginal bleeding. There is no evidence that the use of “natural” estrogens results in a different endometrial risk profile than synthetic estrogens at equivalent estrogen doses. (See WARNINGS, Malignant neoplasms, Endometrial cancer.) CARDIOVASCULAR AND OTHER RISKS Estrogens with or without progestins should not be used for the prevention of cardiovascular disease. (See WARNINGS, Cardiovascular disorders.) The Women’s Health Initiative (WHI) study reported increased risks of myocardial infarction, stroke, invasive breast cancer, pulmonary emboli, and deep vein thrombosis in postmenopausal women (50 to 79 years of age) during 5 years of treatment with oral conjugated estrogens (CE 0.625 mg) combined with medroxyprogesterone acetate (MPA 2.5 mg) relative to placebo. (See CLINICAL PHARMACOLOGY, Clinical Studies). The Women’s Health Initiative Memory Study (WHIMS), a substudy of WHI, reported increased risk of developing probable dementia in postmenopausal women 65 years of age or older during 4 years of treatment with oral conjugated estrogens plus medroxyprogesterone acetate relative to placebo. It is unknown whether this finding applies to younger postmenopausal women or to women taking estrogen alone therapy. (See CLINICAL PHARMACOLOGY, Clinical Studies.) Other doses of oral conjugated estrogens with medroxyprogesterone acetate, and other combinations and dosage forms of estrogens and progestins were not studied in the WHI clinical trials and, in the absence of comparable data, these risks should be assumed to be similar.
    [Show full text]
  • Markedly Inhibited 7-Dehydrocholesterol-Delta 7-Reductase Activity in Liver Microsomes from Smith-Lemli-Opitz Homozygotes
    Markedly inhibited 7-dehydrocholesterol-delta 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes. S Shefer, … , T C Chen, M F Holick J Clin Invest. 1995;96(4):1779-1785. https://doi.org/10.1172/JCI118223. Research Article We investigated the enzyme defect in late cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome, a recessively inherited developmental disorder characterized by facial dysmorphism, mental retardation, and multiple organ congenital anomalies. Reduced plasma and tissue cholesterol with increased 7-dehydrocholesterol concentrations are biochemical features diagnostic of the inherited enzyme defect. Using isotope incorporation assays, we measured the transformation of the precursors, [3 alpha- 3H]lathosterol and [1,2-3H]7-dehydrocholesterol into cholesterol by liver microsomes from seven controls and four Smith-Lemli-Opitz homozygous subjects. The introduction of the double bond in lathosterol at C- 5[6] to form 7-dehydrocholesterol that is catalyzed by lathosterol-5-dehydrogenase was equally rapid in controls and homozygotes liver microsomes (120 +/- 8 vs 100 +/- 7 pmol/mg protein per min, P = NS). In distinction, the reduction of the double bond at C-7 [8] in 7-dehydrocholesterol to yield cholesterol catalyzed by 7-dehydrocholesterol-delta 7- reductase was nine times greater in controls than homozygotes microsomes (365 +/- 23 vs 40 +/- 4 pmol/mg protein per min, P < 0.0001). These results demonstrate that the pathway of lathosterol to cholesterol in human liver includes 7- dehydrocholesterol as a key intermediate. In Smith-Lemli-Opitz homozygotes, the transformation of 7-dehydrocholesterol to cholesterol by hepatic microsomes was blocked although 7-dehydrocholesterol was produced abundantly from lathosterol.
    [Show full text]
  • 01 Front.Pdf
    Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and private study only. The thesis may not be reproduced elsewhere without the permission of the Author. STUDIES TOWARDS THE DEVELOPMENT OF A MULTI­ PURPOSE HOME SELF-TEST KIT FOR THE DETECTION OF URINARY TETRAHYDROCORTISONE AND TESTOSTERONE METABOLITES A thesis submitted in partial fulfilment of the requirements for the degree of Master of Science in Chemistry at Massey University Claire Margaret Nielsen 2003 ii Abstract The development of homogeneous enzyme immunoassays (HEIA) for testosterone glucuronide (TG) and tetrahydrocortisone glucuronide (THEG) in urine are described. The proposed test system is based on the Ovarian Monitor homogeneous immunoassay system, established by J.B Brown and L.F. Blackwell et al. 1 as a simple, laboratory accurate, monitoring device for the measurement of estrone glucuronide (E1G) and pregnanediol glucuronide (PdG) as markers of the fertile phase during a womans menstrual cycle. This information can be used readily by women to identify their cyclical periods of fertility and infertility. The major testosterone metabolite in the urine of males, testosterone p-glucuronide, was synthesised by firstly preparing the glycosyl donor a-bromosugar and conjugating this with testosterone under standard Koenigs-Knorr conditions. 1H nmr studies confirmed that the synthetic steroid glucuronide had the same stereochemistry as the naturally occurring urinary testosterone glucuronide. Testosterone glucuronide and tetrahydrocortisone glucuronide conjugates of hen egg white lysozyme were prepared using the active ester coupling method in good yield. Unreacted lysozyme was successfully removed from the reaction mixture by a combination of cation­ exchange chromatography in 7 M urea and hydrophobic-interaction chromatography.
    [Show full text]
  • Campro Catalog Stable Isotope
    Introduction & Welcome Dear Valued Customer, We are pleased to present to you our Stable Isotopes Catalog which contains more than three thousand (3000) high quality labeled compounds. You will find new additions that are beneficial for your research. Campro Scientific is proud to work together with Isotec, Inc. for the distribution and marketing of their stable isotopes. We have been working with Isotec for more than twenty years and know that their products meet the highest standard. Campro Scientific was founded in 1981 and we provide services to some of the most prestigious universities, research institutes and laboratories throughout Europe. We are a research-oriented company specialized in supporting the requirements of the scientific community. We are the exclusive distributor of some of the world’s leading producers of research chemicals, radioisotopes, stable isotopes and environmental standards. We understand the requirements of our customers, and work every day to fulfill them. In working with us you are guaranteed to receive: - Excellent customer service - High quality products - Dependable service - Efficient distribution The highly educated staff at Campro’s headquarters and sales office is ready to assist you with your questions and product requirements. Feel free to call us at any time. Sincerely, Dr. Ahmad Rajabi General Manager 180/280 = unlabeled 185/285 = 15N labeled 181/281 = double labeled (13C+15N, 13C+D, 15N+18O etc.) 186/286 = 12C labeled 182/282 = d labeled 187/287 = 17O labeled 183/283 = 13C labeleld 188/288 = 18O labeled 184/284 = 16O labeled, 14N labeled 189/289 = Noble Gases Table of Contents Ordering Information.................................................................................................. page 4 - 5 Packaging Information ..............................................................................................
    [Show full text]
  • Aspartic Acid Agonist, in the Mammalian Striatum
    The Journal of Neuroscience August 1986, 6(8): 2226-2234 /II Vitro Release and Electrophysiological Effects In Situ of Homocysteic Acid, An Endogenous N-Methyl-(D)-aspartic Acid Agonist, in the Mammalian Striatum Kim Quang DO,* Paul L. Herrling,? Peter Streit,* Waldemar A. Turski,“fsl and Michel Cuenod* *Brain Research Institute, University of Zurich, Zurich, Switzerland, and j-Wander Research Institute, Bern, Switzerland A potassium-induced, calcium-dependent release of endogenous fects of microiontophoretically applied (L)-HCA on membrane homocysteic acid (HCA) from rat striatal slices was demonstrat- potential and cortically evoked EPSPsin cat caudate neurons, ed. A precolumn derivatization high-performance liquid chro- and the pharmacologicalspecificity of (L)-HCA in this structure. matography method was developed that allowed quantitative de- termination of sulfur-containing amino acids at the picomole level. Materials and Methods Intracellular recordings from cat caudate neurons during si- Materials multaneous microiontophoretic application of drugs and electri- cal stimulation of the corticocaudate pathway showed that (L> Release HCA evoked a depolarization pattern similar to that induced 4-N,N-Dimethylamino-azobenzene-4’-isotbiocyanate (DABITC) was ob- by %methyl-(D>aspartic acid (NMDA), and both these depo- tained from Fluka (Buchs, CH) and recrystallized in acetone (Merck, larizations could be selectively inhibited by a specific NMDA Darmstadt, FRG). All other solvents used were ofcommercial analytical antagonist, (D)-Z-amino-7-phosphonoheptanoicacid [(D)-AP-~]. grade from Merck or Fluka. The internal standard (D,L)-2-amino-7- A selective antagonismof (rJ-HCA-induced depolarizations by sulfonoheptanoic acid (AS-7) was a generous gift of Dr. J. C. Watkins. (L)-homocysteic acid [(L)-HCA], (L)-cysteine sulfinic acid [(L)-CSA], (L)- (D>AP-~ was confirmed in quantitative experiments with the cysteic acid [(L)-CA], and veratrine were purchased from Sigma (St.
    [Show full text]
  • Treatment Protocol Copyright © 2018 Kostoff Et Al
    Prevention and reversal of Alzheimer's disease: treatment protocol Copyright © 2018 Kostoff et al PREVENTION AND REVERSAL OF ALZHEIMER'S DISEASE: TREATMENT PROTOCOL by Ronald N. Kostoffa, Alan L. Porterb, Henry. A. Buchtelc (a) Research Affiliate, School of Public Policy, Georgia Institute of Technology, USA (b) Professor Emeritus, School of Public Policy, Georgia Institute of Technology, USA (c) Associate Professor, Department of Psychiatry, University of Michigan, USA KEYWORDS Alzheimer's Disease; Dementia; Text Mining; Literature-Based Discovery; Information Technology; Treatments Prevention and reversal of Alzheimer's disease: treatment protocol Copyright © 2018 Kostoff et al CITATION TO MONOGRAPH Kostoff RN, Porter AL, Buchtel HA. Prevention and reversal of Alzheimer's disease: treatment protocol. Georgia Institute of Technology. 2018. PDF. https://smartech.gatech.edu/handle/1853/59311 COPYRIGHT AND CREATIVE COMMONS LICENSE COPYRIGHT Copyright © 2018 by Ronald N. Kostoff, Alan L. Porter, Henry A. Buchtel Printed in the United States of America; First Printing, 2018 CREATIVE COMMONS LICENSE This work can be copied and redistributed in any medium or format provided that credit is given to the original author. For more details on the CC BY license, see: http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License<http://creativecommons.org/licenses/by/4.0/>. DISCLAIMERS The views in this monograph are solely those of the authors, and do not represent the views of the Georgia Institute of Technology or the University of Michigan. This monograph is not intended as a substitute for the medical advice of physicians. The reader should regularly consult a physician in matters relating to his/her health and particularly with respect to any symptoms that may require diagnosis or medical attention.
    [Show full text]
  • Endogenous Metabolites: JHU NIMH Center Page 1
    S. No. Amino Acids (AA) 24 L-Homocysteic acid 1 Glutaric acid 25 L-Kynurenine 2 Glycine 26 N-Acetyl-Aspartic acid 3 L-arginine 27 N-Acetyl-L-alanine 4 L-Aspartic acid 28 N-Acetyl-L-phenylalanine 5 L-Glutamine 29 N-Acetylneuraminic acid 6 L-Histidine 30 N-Methyl-L-lysine 7 L-Isoleucine 31 N-Methyl-L-proline 8 L-Leucine 32 NN-Dimethyl Arginine 9 L-Lysine 33 Norepinephrine 10 L-Methionine 34 Phenylacetyl-L-glutamine 11 L-Phenylalanine 35 Pyroglutamic acid 12 L-Proline 36 Sarcosine 13 L-Serine 37 Serotonin 14 L-Tryptophan 38 Stachydrine 15 L-Tyrosine 39 Taurine 40 Urea S. No. AA Metabolites and Conjugates 1 1-Methyl-L-histidine S. No. Carnitine conjugates 2 2-Methyl-N-(4-Methylphenyl)alanine 1 Acetyl-L-carnitine 3 3-Methylindole 2 Butyrylcarnitine 4 3-Methyl-L-histidine 3 Decanoyl-L-carnitine 5 4-Aminohippuric acid 4 Isovalerylcarnitine 6 5-Hydroxylysine 5 Lauroyl-L-carnitine 7 5-Hydroxymethyluracil 6 L-Glutarylcarnitine 8 Alpha-Aspartyl-lysine 7 Linoleoylcarnitine 9 Argininosuccinic acid 8 L-Propionylcarnitine 10 Betaine 9 Myristoyl-L-carnitine 11 Betonicine 10 Octanoylcarnitine 12 Carnitine 11 Oleoyl-L-carnitine 13 Creatine 12 Palmitoyl-L-carnitine 14 Creatinine 13 Stearoyl-L-carnitine 15 Dimethylglycine 16 Dopamine S. No. Krebs Cycle 17 Epinephrine 1 Aconitate 18 Hippuric acid 2 Citrate 19 Homo-L-arginine 3 Ketoglutarate 20 Hydroxykynurenine 4 Malate 21 Indolelactic acid 5 Oxalo acetate 22 L-Alloisoleucine 6 Succinate 23 L-Citrulline 24 L-Cysteine-glutathione disulfide Semi-quantitative analysis of endogenous metabolites: JHU NIMH Center Page 1 25 L-Glutathione, reduced Table 1: Semi-quantitative analysis of endogenous molecules and their derivatives by Liquid Chromatography- Mass Spectrometry (LC-TripleTOF “or” LC-QTRAP).
    [Show full text]
  • Hypothalamic Principles Necessary for the Release of Ovulating Hormone from the Adenohypophysis
    EFFECT OF AMINOGLUTETHIMIDE ON REPRODUCTIVE PROCESSES IN FEMALE RATS W. J. EVERSOLE and D. J. THOMPSON Department of Life Sciences, Indiana State University, Terre Haute, Indiana 47809, U.S.A. (Received "òlst January 1974) Summary. Adult female rats injected subcutaneously with 100 mg aminoglutethimide phosphate (AGP)/kg/day for 4 weeks failed to become pregnant when placed in cohabitation with males during the last 2 weeks of the injection period. Lower doses depressed the fertility rate and reduced the litter size: the average litter size of three of eleven rats given 50 mg/kg/day was 4\m=.\7 young and of four of eleven rats given 25 mg was 7\m=.\0 young. Twenty-nine controls averaged 10\m=.\1/litter. Doses of 100 mg AGP/kg/day stopped vaginal cycling, prevented ovulation in adults, and delayed dissolution of the vaginal membrane in pubertal rats. Histological studies of the ovaries from rats with initial ages of 17 or 21 days which were injected with 25 to 100 mg AGP/kg/day for 2 weeks showed an increase in the number and size of vesicular follicles. Treatment of 27-day-old rats with 25 mg/kg/day for 2 weeks reduced the number of CL and three of four rats given 50 mg had ovaries lacking such bodies; all control ovaries in this group contained CL. These findings are taken as evidence that AGP inhibits ovulation but does not prevent follicular maturation. INTRODUCTION Many pharmacological compounds originally developed as anaesthetics, tranquillizers and anticonvulsants modify endocrine structures and functions (see Gaunt, Chart & Renzi, 1965).
    [Show full text]
  • Synthesis of Optically Pure Macroheterocycles with 2,6-Pyridinedicarboxylic and Adipic Acid Fragments from ∆3-Carene
    Macrolides Paper Макролиды Статья DOI: 10.6060/mhc190660y Synthesis of Optically Pure Macroheterocycles with 2,6-Pyridinedicarboxylic and Adipic Acid Fragments from ∆3-Carene Marina P. Yakovleva,@ Kseniya S. Denisova, Galina R. Mingaleeva, Valentina A. Vydrina, and Gumer Yu. Ishmuratov Ufa Institute of Chemistry, Ufa Federal Research Center, Russian Academy of Sciences, 450054 Ufa, Russia @Corresponding author E-mail: [email protected] Based on the available natural monoterpene ∆3-carene we have developed the synthesis of four optically pure macroheterocycles with ester and dihydrazide fragments through the intermediate 1-((1S,3R)-3-(2-hydroxyethyl- 2,2-dimethylcyclopropyl)propan-2-one using its [2+1]-interaction with dichloranhydrides of adipic or 2,6-pyridinedicarboxylic acids and [1+1]-condensation of the obtained α,ω-diketodiesters with dihydrazides of adipic or 2,6-pyridinedicarboxylic acids. The structure of new compounds was confirmed by IR and NMR spectroscopy and mass spectrometry. Keywords: 3-Carenes, ozonolysis, sodium hypochlorite, macroheterocycles with ester and dihydrazide fragments, [2+1] and [1+1] condensations, synthesis. Синтез оптически чистых макрогетероциклов со сложноэфирными и дигидразидными фрагментами адипиновой и 2,6-пиридиндикарбоновой кислот из D3-карена М. П. Яковлева,@ К. С. Денисова, Г. Р. Мингалеева, В. А. Выдрина, Г. Ю. Ишмуратов Уфимский Институт химии – обособленное структурное подразделение Федерального бюджетного научного учреждения Уфимского федерального исследовательского центра Российской академии
    [Show full text]
  • Comprehensive Urinary Hormone Assessments
    ENDOCRINOLOGY Complete Hormones – Analytes Comprehensive Urinary Hormone Assessments Urinary Pregesterones Urinary Glucocorticoids Urinary Androgens Urinary Estrogens Pregnanediol Cortisol, Free Testosterone Estrone Pregnanetriol Total 17-Hydroxy-corticosteroids Dehydroepiandrosterone (DHEA) Estradiol allo-Tetrahydrocortisol, a-THF Total 17-Ketosteroids Estriol Tetrahydrodeoxycortisol Androsterone 2-Hydroxyestrone Tetrahydrocortisol, THF Etiocholanolone 2-Methoxyestrone Tetrahydrocortisone, THE 11-Keto-androsterone 4-Hydroxyestrone 17-Hydroxysteriods, Total 11-Keto-etiocholanolone 4-Methoxyestrone Pregnanetriol 11-Hydroxy-androsterone 16α-Hydroxyestrone 11-Hydroxy-etiocholanolone 2-Hydroxy-estrone:16α-Hydroxyestrone ratio 2-Methoxyestrone:2-Hydroxyestrone ratio CLINICIAN INFORMATION 4-Methoxyestrone:4-Hydroxyestrone ratio ADVANCING THE CLINICAL UTILITY OF URINARY HORMONE ASSESSMENT Specimen Requirements Complete Hormones™ is Genova’s most comprehensive • 120 ml aliquot, refrigerated until shipped, urinary hormone profile, and is designed to assist with the from either First Morning Urine or 24-Hour clinical management of hormone-related symptoms. This profile Collection Why Use Complete Hormones? assesses parent hormones and their metabolites as well as key metabolic pathways, and provides insight into the contribution Hormone testing is an effective tool for assessing Related Profiles: that sex hormones may have in patients presenting with and managing patients with hormone- related symptoms. This profile supports: • Male Hormonal Health™
    [Show full text]
  • SCOMET List 2013
    (Annexure to Notification No. 37(RE-2012)/2009-2014 Dated 14.03.2013) Special Chemicals, Organisms, Materials, Equipment and Technologies (SCOMET) export of which is regulated Export of Special Chemicals, Organisms, Materials, Equipment and Technologies (SCOMET) listed below shall be permitted only against an export licence issued in this behalf unless export is prohibited or is permitted without licence subject to fulfillment of conditions, if any, as indicated under/against any specific category or item. Provisions of Chapter IV A of the FT(D&R) Act,1992 as amended in 2010 shall apply to the goods, services and technologies specified in the list below. Supply of SCOMET Items from DTA to SEZ No export permission is required for supply of SCOMET items from DTA to SEZ. However, all supplies of SCOMET items from DTA to SEZ will be reported to the Development Commissioner of the respective SEZ by the supplier in the prescribed proforma (Annexure 1) within one (1) week of the supplies getting effected. An annual report of such supplies from DTA to SEZ shall be sent to SCOMET Cell, DGFT (Hqrs), Department of Commerce, Udyog Bhawan, Maulana Azad Road, New Delhi-110011, by the Development Commissioner (DC), SEZ in the prescribed proforma (Annexure 2) . Report by the DC, SEZ to be filed by 15th May of every financial year for the supplies effected during the preceding financial year. Export of SCOMET Items from SEZ to outside the country Export permission is required if the SCOMET items are to be physically exported outside the country from SEZ i.e.
    [Show full text]